| [1] |
Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2016, 387(10015): 251-272.
|
| [2] |
Wong LK. Global burden of intracranial atherosclerosis[J]. Int J Stroke, 2006, 1(3): 158-159.
|
| [3] |
Kim JS, Bang OY. Medical treatment of intracranial atherosclerosis: an update[J]. J Stroke, 2017, 19(3): 261-270.
|
| [4] |
Grubb RJ, Powers WJ, Clarke WR, et al. Surgical results of the Carotid Occlusion Surgery Study[J]. J Neurosurg, 2013, 118(1): 25-33.
|
| [5] |
Sundt TJ, Smith HC, Campbell JK, et al. Transluminal angioplasty for basilar artery stenosis[J]. Mayo Clin Proc, 1980,55(11): 673-680.
|
| [6] |
Aghaebrahim A, Agnoletto GJ, Aguilar-Salinas P, et al. Endovascularrecanalization of symptomatic intracranial arterial stenosis despite aggressive medical management[J]. World Neurosurg, 2019, 123: e693-e699.
|
| [7] |
Duan G, Feng Z, Zhang L, et al. Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation[J]. J Neurointerv Surg, 2016, 8(7): 680-684.
|
| [8] |
Alexander MJ, Zauner A, Chaloupka JC, et al. WEAVE trial: final results in 152 on-label patients[J]. Stroke, 2019, 50(4): 889-894.
|
| [9] |
Du Z, Mang J, Yu S, et al. Weighing in on the off-label use: initial experience of Neuroform EZ stenting for intracranial arterial stenosis in 45 patients[J]. Frontiers in Neurology, 2018, 9: 852.
|
| [10] |
Vajda Z, Schmid E, Guthe T, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent[J]. Neurosurgery, 2012, 70(1): 91-101.
|
| [11] |
邱县生，丁乙夫，夏少怀, 等. Enterprise支架治疗复杂症状性颅内动脉粥样硬化性重度狭窄的效果评价[J]. 中国脑血管病杂志, 2019, 16(05): 257-262.
|
| [12] |
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis[J]. N Engl J Med, 2005, 352(13): 1305-1316.
|
| [13] |
Suzuki Y, Nakajima M, Ikeda H, et al. Evaluation of hyperacute stroke using perfusion computed tomography[J]. Neurol Med Chir (Tokyo), 2005, 45(7): 333-343, 341-343.
|
| [14] |
贾子昌，卞焕菊，李选, 等. Neuroform EZ支架在治疗复杂症状性颅内动脉重度狭窄中的应用[J]. 北京大学学报(医学版), 2019, 51(5): 835-839.
|
| [15] |
Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of40 patients[J]. Stroke, 2004, 35(6): 1375-1380.
|
| [16] |
Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty[J]. AJNR Am J Neuroradiol, 1998, 19(8): 1525-1533.
|
| [17] |
Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis:a diffusion-weighted imaging and microemboli monitoring study[J]. Ann Neurol, 2002, 52(1): 74-81.
|
| [18] |
Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis[J]. Circulation, 2006, 113(4): 555-563.
|
| [19] |
Turan TN, Smock A, Chimowitz MI. The challenge of stroke prevention with intracranial arterial stenosis[J]. Curr Cardiol Rep, 2013, 15(12): 422.
|
| [20] |
高峰，杜彬，姜卫剑, 等. Wingspan支架治疗国人症状性颅内动脉狭窄的初步经验[J]. 中国卒中杂志, 2007(07): 569-573.
|
| [21] |
Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J].N Engl J Med, 2011, 365(11): 993-1003.
|
| [22] |
Yu SC, Leung TW, Lee KT, et al. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients[J]. J Neurointerv Surg, 2014, 6(3): 212-218.
|
| [23] |
Fujimoto M, Shobayashi Y, Takemoto K, et al. Structural analysis for Wingspan stent in a perforator model[J]. Interv Neuroradiol, 2013, 19(3): 271-275.
|
| [24] |
Krischek O, Miloslavski E, Fischer S, et al. A comparison of functional and physical properties of self-expanding intracranial stents [Neuroform3, Wingspan, Solitaire, Leo+, Enterprise][J]. Minim Invasive Neurosurg, 2011, 54(1): 21-28.
|
| [25] |
Shin YS, Kim BM, Suh SH, et al. Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis[J]. Neurosurgery, 2013, 72(4): 596-604.
|
| [26] |
Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis[J]. Neurology, 2008, 70(17): 1518-1524.
|
| [27] |
Costalat V, Maldonado IL, Vendrell JF, et al. Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results[J]. J Neurosurg, 2011, 115(4): 686-693.
|
| [28] |
陈旭，孙硕，佟小光. 颅内动脉狭窄支架成形术后支架内急性血栓形成相关研究[J]. 介入放射学杂志, 2016, 25(3): 189-192.
|
| [29] |
Yue X, Yin Q, Xi G, et al. Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis[J]. Cardiovasc Intervent Radiol, 2011, 34(1): 54-60.
|
| [30] |
Grossmann R, Sokolova O, Schnurr A, et al. Variable extent of clopidogrel responsiveness in patients after coronary stenting[J]. Thromb Haemost, 2004, 92(6): 1201-1206.
|
| [31] |
李倩，徐达，陈邓, 等. 颅内动脉狭窄支架植入术后支架内再狭窄危险因素Meta分析[J]. 中国现代神经疾病杂志, 2018, 18(3): 183-191.
|